New hope for lung cancer patients who can't take chemo
NCT ID NCT07295821
First seen Jan 11, 2026 · Last updated May 14, 2026 · Updated 20 times
Summary
This study tests a drug called osimertinib, given before and after radiation, for people with stage III lung cancer that has a specific gene mutation (EGFR). Participants are those who cannot or choose not to have chemotherapy. The goal is to see if this approach helps control the cancer longer. About 60 adults will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
NOT_YET_RECRUITINGBeijing, 100021, China
-
Research Site
NOT_YET_RECRUITINGBeijing, 100730, China
-
Research Site
NOT_YET_RECRUITINGChangchun, 130021, China
-
Research Site
NOT_YET_RECRUITINGChangsha, 410013, China
-
Research Site
NOT_YET_RECRUITINGChengdu, 610041, China
-
Research Site
NOT_YET_RECRUITINGFoshan, 528000, China
-
Research Site
NOT_YET_RECRUITINGFuzhou, 350011, China
-
Research Site
NOT_YET_RECRUITINGGuangzhou, 510060, China
-
Research Site
RECRUITINGGuangzhou, 510100, China
-
Research Site
NOT_YET_RECRUITINGHarbin, 150081, China
-
Research Site
NOT_YET_RECRUITINGHefei, 230031, China
-
Research Site
NOT_YET_RECRUITINGJinan, 250021, China
-
Research Site
NOT_YET_RECRUITINGKunming, 650118, China
-
Research Site
NOT_YET_RECRUITINGNanchang, 330006, China
-
Research Site
NOT_YET_RECRUITINGQingdao, 110016, China
-
Research Site
NOT_YET_RECRUITINGShanghai, 200120, China
-
Research Site
NOT_YET_RECRUITINGShanghai, 200433, China
-
Research Site
NOT_YET_RECRUITINGTaiyuan, 030000, China
-
Research Site
RECRUITINGWenzhou, 325000, China
-
Research Site
NOT_YET_RECRUITINGXuzhou, 221000, China
Conditions
Explore the condition pages connected to this study.